Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,329
Total Claims
$668K
Drug Cost
969
Beneficiaries
$689
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-41%
Cost per patient vs peers
$689 vs $1,174 avg
+13%
Brand preference vs peers
10.0% vs 8.9% avg
Brand vs Generic
Brand: 931 claims · $502K
Generic: 8,337 claims · $163K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 101 | $99K |
| Semaglutide | 84 | $76K |
| Semaglutide | 28 | $41K |
| Fluticasone/Vilanterol | 65 | $38K |
| Lipase/Protease/Amylase | 16 | $29K |
| Tirzepatide | 21 | $25K |
| Rivaroxaban | 21 | $21K |
| Lipase/Protease/Amylase | 15 | $19K |
| Insulin Glargine,hum.Rec.Anlog | 24 | $12K |
| Levothyroxine Sodium | 395 | $8,769 |
| Fluticasone Propion/Salmeterol | 14 | $8,327 |
| Atorvastatin Calcium | 446 | $5,942 |
| Albuterol Sulfate | 102 | $5,795 |
| Gabapentin | 187 | $5,385 |
| Rosuvastatin Calcium | 250 | $4,998 |
Prescribing Profile
Patient Profile
75
Avg Age
54%
Female
1.81
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data